CN210159082U

CN210159082U - Novel double-air-bag local chemotherapy device for esophageal cancer

Info

Publication number: CN210159082U
Application number: CN201822240388.9U
Authority: CN
Inventors: 彭云; 范加梅; 余登梅
Original assignee: Individual
Current assignee: Individual
Priority date: 2018-12-28
Filing date: 2018-12-28
Publication date: 2020-03-20
Anticipated expiration: 2028-12-28

Abstract

The utility model relates to a clinical medicine technical field specifically is a novel local chemotherapy ware of two gasbag esophagus cancer, include body, aerating device, gas-supply pipe, first gas tube, second gas tube, advance pencil, nutrition tube, first gasbag, second gasbag and mark ring. The utility model has the advantages that: the contact absorption of the tumor tissue and the mucosa is carried out in a static state, so adverse reaction is not generated, the pain of a patient is reduced, and a contrast agent or a barium agent is not needed for positioning.

Description

Novel double-air-bag local chemotherapy device for esophageal cancer

Technical Field

The utility model relates to the technical field of medical equipment, in particular to a novel double-air-bag local chemotherapy device for esophageal cancer.

Background

Esophageal cancer is a common malignant tumor in clinic, and limited by geographical positions, environmental conditions and medical conditions, the number of patients who can obtain early surgical treatment opportunities is less than 30%, and fewer radical treatments can be obtained. Most patients develop to middle and late stages due to late visit, the chance of surgical treatment is lost, and treatment methods of whole-body chemotherapy and radiotherapy have to be adopted. But has the disadvantages of large toxic and side effects, low sensitivity of esophagus cancer to chemotherapy drugs and the like, so the effect is not good.

At present, the clinical chemotherapy method and approach for esophagus malignant tumor are the same as those of other cancers, venous chemotherapy is adopted, high-concentration medicines are directly contacted and absorbed through tumor tissues and mucous membranes to soften and shrink the tumor mass, and blood supply of the esophagus is blood supply to nourish the blood vessels, so that the local esophagus cannot be necrotized due to compression. The contact absorption of tumor tissues and mucosa is performed in a dynamic state, thus causing other adverse reactions, increasing the pain of patients, and requiring contrast agents or barium agents to determine the position.

SUMMERY OF THE UTILITY MODEL

To the weak point among the above-mentioned prior art, the utility model aims at providing a novel two gasbag esophagus cancer local chemotherapy wares that tumour tissue and mucosa's contact absorption were gone on under quiescent condition, can not bring other adverse reactions, and do not need contrast medium or barium agent definite position.

In order to solve the technical problems, the utility model provides a novel double-airbag esophageal cancer local chemotherapy device, which comprises a tube body, an inflation device, a gas tube, a first inflation tube, a second inflation tube, a medicine inlet tube, a nutrition tube, a first airbag, a second airbag and a mark ring, wherein the first inflation tube is arranged on the left side of the tube body, the second inflation tube is arranged on the right side of the tube body, the nutrition tube is arranged on the central part of the tube body, the medicine inlet tube is arranged in the nutrition tube, the tube body, the first inflation tube, the second inflation tube and the nutrition tube are integrally arranged, the upper ends of the first inflation tube and the second inflation tube are respectively provided with a sealing plug, the side surfaces of the first inflation tube and the second inflation tube are respectively provided with an air inlet, the gas tube is a three-way tube, the two ends of the gas tube are respectively connected with the air inlets of the first inflation tube and the second inflation tube, and the first, the utility model discloses a medicine feeding tube, including body, stand, first gas bag, first gas channel, medicine inlet pipe, medicine outlet hole, nutrition tube, sign ring, first gas bag and second gas bag, the body lower extreme is provided with first gasbag and second gasbag, the sign ring sets up respectively in first gasbag and second gasbag upper end, be provided with first gas runner in the first gas tube, be provided with the second gas runner in the second gas tube, first gas runner and second gasbag intercommunication, second gas runner and first gasbag intercommunication, medicine inlet pipe afterbody has seted up out the medicine hole, the discharge hole has been seted up to nutrition tube afterbody.

Wherein, a control valve is arranged on the gas transmission pipe.

Wherein, the upper end of the medicine inlet pipe is provided with a medicine inlet funnel.

Wherein, the inflation device is a pedal air bag.

Wherein, the mark ring is made of fluorescent material.

Wherein the number of the outflow holes is at least 2.

The utility model has the advantages that: the utility model discloses make the contact absorption of tumour tissue and mucosa go on under static state, the event can not produce the adverse reaction, has reduced patient's misery, and does not need contrast medium or barium agent to fix a position.

Drawings

Fig. 1 is a schematic structural view of the present invention;

fig. 2 is a schematic structural view of a first inflation tube portion of the present invention.

Detailed Description

The technical solution in the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present invention.

As shown in figures 1-2, the utility model relates to a novel double-air-bag esophageal cancer local chemotherapy device, which comprises a tube body 1, an inflation device 2, an air delivery tube 3, a first inflation tube 4, a second inflation tube 5, an medicine inlet tube 6, a nutrition tube 7, a first air bag 8, a second air bag 9 and a mark ring 10, wherein the first inflation tube 4 is arranged at the left side of the tube body 1, the second inflation tube (5) is arranged at the right side of the tube body 1, the nutrition tube 7 is arranged at the central part of the tube body 1, the medicine inlet tube 6 is arranged in the nutrition tube 7, the tube body 1, the first inflation tube 4, the second inflation tube 5 and the nutrition tube 7 are integrally arranged, the upper ends of the first inflation tube 4 and the second inflation tube 5 are both provided with a sealing plug 11, the side surfaces of the first inflation tube 4 and the second inflation tube 5 are both provided with an air inlet 12, the air delivery tube 3 is a three-way tube, and the two ends of the air delivery tube 3 are respectively connected with the air inlet 12 of the, the third end of gas-supply pipe 3 is connected with

aerating device

2, 1 lower extreme of body is provided with first gasbag 8 and second gasbag 9, mark ring 10 sets up respectively in first gasbag 8 and second gasbag 9 upper end, be provided with first gas runner 41 in the first gas tube 4, be provided with second gas runner 51 in the second gas tube 5, first gas runner 41 and second gasbag 9 intercommunication, second gas runner 51 and first gasbag 8 intercommunication, medicine outlet 61 has been seted up to 6 afterbody of medicine inlet pipe, outlet 71 has been seted up to 7 afterbody of nutrition tube.

Furthermore, the gas pipe 3 is provided with a control valve 31, which is convenient for controlling the inflation flow.

Furthermore, a medicine inlet funnel 13 is arranged at the upper end of the medicine inlet pipe 6, so that liquid medicine is convenient to convey, and leakage of the liquid medicine is prevented.

Further, the inflating device 2 is a pedal airbag, so that the first airbag 8 and the second airbag 9 can be inflated conveniently.

Further, the marker ring 10 is made of fluorescent material, so that the position can be observed conveniently.

Further, the number of the outflow holes 71 is at least 2.

Specifically, the intubation method and the steps are the same as the method for inserting the gastric tube, after intubation, the first air bag 8 or the second air bag 9 is arranged at the upper end and the lower end of a lesion part of the esophagus, the distance between the upper end and the lower end of the lesion part of the esophagus is proper, the depth of intubation is determined according to an esophagoscope and a mark ring 10, after the second air bag 9 passes through the lesion part by 10mm, the first air bag 8 and the second air bag 9 are inflated by an inflating device to block the upper end and the lower end of the lesion part of the esophagus so as not to press the normal blood circulation of the esophagus (each air bag is inflated by about 20ml), chemotherapeutic drugs are pushed into the esophagus at the upper section of the lesion by the drug inlet tube 8 to be inflated to block the esophagus, thereby forming an esophagus sealing cavity between the two air bags, the drugs can act on the lesion part in the stomach for a long time, and can not flow into or reflux the stomach, the activities and nutrition intake of a patient can not be blocked, the tail part of the nutrition tube 7 is provided with an outflow hole 71 for pushing medicine and absorbing nutrient substances, thereby forming a double-air-bag four-cavity tube local chemotherapy device for esophageal cancer, accelerating the chemotherapy speed and simultaneously improving the working efficiency.

Claims

1. A novel double-balloon local chemotherapy device for esophageal cancer is characterized in that: comprises a tube body (1), an inflation device (2), a gas pipe (3), a first inflation pipe (4), a second inflation pipe (5), a medicine inlet pipe (6), a nutrition tube (7), a first air bag (8), a second air bag (9) and a mark ring (10), wherein the first inflation pipe (4) is arranged on the left side of the tube body (1), the second inflation pipe (5) is arranged on the right side of the tube body (1), the nutrition tube (7) is arranged at the central part of the tube body (1), the medicine inlet pipe (6) is arranged in the nutrition tube (7), the tube body (1), the first inflation pipe (4), the second inflation pipe (5) and the nutrition tube (7) are integrally arranged, sealing plugs (11) are arranged at the upper ends of the first inflation pipe (4) and the second inflation pipe (5), and gas inlets (12) are arranged on the side surfaces of the first inflation pipe (4) and the second inflation pipe (5), the gas transmission pipe (3) is a three-way pipe, two ends of the gas transmission pipe (3) are respectively connected with the gas inlets (12) of the first inflation pipe (4) and the second inflation pipe (5), the third end of the gas transmission pipe (3) is connected with the inflation device (2), the lower end of the tube body (1) is provided with a first air bag (8) and a second air bag (9), the mark rings (10) are respectively arranged at the upper ends of the first air bag (8) and the second air bag (9), a first gas flow passage (41) is arranged in the first gas filling pipe (4), a second gas flow passage (51) is arranged in the second gas filling pipe (5), the first gas flow channel (41) is communicated with the second air bag (9), the second gas flow channel (51) is communicated with the first air bag (8), the tail part of the medicine inlet pipe (6) is provided with a medicine outlet hole (61), and the tail part of the nutrition pipe (7) is provided with an outlet hole (71); the upper end of the medicine inlet pipe (6) is provided with a medicine inlet funnel (13).

2. The novel dual-balloon local chemotherapy device for esophageal cancer as claimed in claim 1, wherein: the gas transmission pipe (3) is provided with a control valve (31).

3. The novel dual-balloon local chemotherapy device for esophageal cancer as claimed in claim 1, wherein: the inflating device (2) is a pedal airbag.

4. The novel dual-balloon local chemotherapy device for esophageal cancer as claimed in claim 1, wherein: the mark ring (10) is made of fluorescent materials.

5. The novel dual-balloon local chemotherapy device for esophageal cancer as claimed in claim 1, wherein: the number of the outflow holes (71) is at least 2.